A team of medical engineers headed by Prof. Bernhard Wolf at the TUM Heinz Nixdo rf Chair of Medical Electronics have now developed a sens...

Scientists Re-engineer an Antibiotic to Overcome Resistant Bacteria - Topix

Scientists at Yale University have developed the first practical method to create a compound called huperzine A  (see structure below) in ...

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib ( PLX4032/R...

In continuation of my update on green tea Researchers lead by  Dr. Thomas Smith at The Donald Danforth Plant Science Center and his...

European Medicines Agency (EMA) has accepted Pfizer's regulatory submissions for review of two investigational compounds  crizotinib,...

We know that, Linaclotide (BELOW STRUCTURE) is an experimental peptide agonist of guanylate cyclase 2C that is undergoing clinical trials...

A new drug, Rivaroxaban, (see structure) that lowers stroke risk among people with an irregular heartbeat may give the old standby, warfar...

We know that, the compound, ursodeoxycholic acid (UDCA, see structure), is already used to lower cholesterol and help dissolve gallstones,...

In continuation of my update on  carboplatin Researchers from IU Medical Sciences Program-Bloomington  and Indiana University Melvi...

In continuation of my update on Rosiglitazone , The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve dam...

FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

Researchers from Thomas Jefferson University Hospita,  found that taxoxifen combined with dasatinib, a protein-tyrosine kinase inhibitor,...

Researchers are carrying out the final stages of clinical trials of a drug that contains  theobromine  (see structure), an ingredient fou...

Press Announcements FDA approves Xalkori with companion diagnostic for a type of late-stage lung cancer